Clinical Trial Update: The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing glucose control and weight loss effects between Beinaglutide and Dulaglutide in adults with type 2 diabetes and overweight/obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight or Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Beinaglutide (beinaglutide)
• Dulaglutide (dulaglutide)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Diabetes Mellitus, Type 2, Overweight or Obesity | Phase 4 | Status: UNKNOWN